Advertisement

Etiology and Management of the Compromised Patient with Fever and Pulmonary Infiltrates

  • Robert H. Rubin
  • Reginald Greene

Abstract

The immunocompromised patient in whom fever and pneumonitis develop presents a formidable challenge to the clinician. A legion of microbial invaders ranging from common viral and bacterial pathogens to exotic fungal and protozoan agents have been reported to cause pulmonary infection in these patients. Given the array of infectious etiologies, it is little wonder that pneumonia is the most frequent cause of fatal infection in the compromised host.1–8 For example, in one large series of 227 renal transplant patients, inflammatory disease of the lung occurred in 20% of patients and was associated with 50% of fatalities.6 Patients with acute leukemia in relapse develop an episode of pneumonia approximately once every 60 days at risk.9 In patients with hematologic malignancy who developed fever and pulmonary infiltrates, the mortality rate (45%) was five times that for such patients with fever alone.10 In a similar study of pneumonia in patients with cancer, the mortality rate (76%) for patients with pulmonary infection was many time greater than the mortality associated with infection at other sites.10 In most patients with acquired immunodeficiency syndrome (AIDS) pneumonia develops, and in virtually all these patients pneumonia is an important factor in their demise.

Keywords

Invasive Aspergillosis Pulmonary Infection Renal Transplant Patient Pulmonary Infiltrate Radiation Pneumonitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rubin RH: The cancer patient with fever and pulmonary infiltrates; Etiology and diagnostic approach. In Remington JS, Swartz MN (eds): Current Clinical Topics in Infectious Disease Vol. I. McGraw-Hill, New York, 1980, pp. 288303.Google Scholar
  2. 2.
    Levine AS, Schimpff SC, Graw RG, et al: Hematologic malignancies and other marrow failure states: Progress in the management of complicating infections. Semin Hematol 11: 141–202, 1974.PubMedGoogle Scholar
  3. 3.
    Williams DM, Krick JA, Remington JS: Pulmonary infection in the compromised host. Am Rev Respir Dis 114:359–394, 593–627, 1976.Google Scholar
  4. 4.
    Schimpff SC: Diagnosis of infection in patients with cancer. Eur J Cancer (Suppl.) 11: 29–38, 1975.Google Scholar
  5. 5.
    Pennington JE, Feldman NT: Pulmonary infiltrates and fever in patients with hematologic malignancy: Assessment of transbronchial biopsy. Am J Med 62: 581–587, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Ramsey PG, Rubin RH, Tolkoff-Rubin NE, et al: The renal transplant patient with fever and pulmonary infiltrates: Etiology, clinical manifestations, and management. Medicine (Baltimore) 59: 206–222, 1980.Google Scholar
  7. 7.
    Bishop JF, Schimpff SC, Diggs CH, et al: Infections during intensive chemotherapy for non-Hodgkin’s lymphoma. Ann Intern Med 95: 549–555, 1981.PubMedGoogle Scholar
  8. 8.
    Rosenow EC III, Wilson WR, Cockerill FR III: Pulmonary disease in the immunocompromised host. Mayo Clin Proc 60:473–487, 610–631, 1985.Google Scholar
  9. 9.
    Sickles EA, Young VM, Greene WH, et al: Pneumonia in acute leukemia. Ann Intern Med 79: 528–534, 1973.PubMedGoogle Scholar
  10. Singer C, Armstrong D, Rosen PP,: Diffuse pulmonary infiltrates in immunosuppressed patients: Prospective study of 80 cases. Am J Med 66:115–120 1979.Google Scholar
  11. 11.
    Singer C, Kaplan MH, Armstrong D: Bacteremia and fungemia complicating neoplastic disease. Am J Med 62: 731–742, 1977.PubMedCrossRefGoogle Scholar
  12. 12.
    Pennington JE: Infection in the compromised host; recent advances and future directions. In Weinstein L, Fields BN (eds): Seminars in Infectious Disease. Vol. 1. Stratton Intercontinental, New York, 1978, pp. 142–168.Google Scholar
  13. 13.
    Johanson WG Jr, Pierce AK, Sanford JP: Changing pharyngeal bacterial flora of hospitalized patients. N Engl J Med 281: 1137–1140 1969.PubMedCrossRefGoogle Scholar
  14. 14.
    Johanson WG Jr, Higuchi JJ, Chadhuri TR, Woods DE: Bacterial adherence to epithelial cells in bacterial colonization of the respiratory tract. Am Rev Respir Dis 121: 55–63, 1980.PubMedGoogle Scholar
  15. 15.
    Woods DE: Bacterial colonization of the respiratory tract:Clinical significance. In Pennington JE (ed): Respiratory Infections: Diagnosis and Management. Raven, New York, 1983, pp. 25–29.Google Scholar
  16. 16.
    Beatty HN, Miller AA, Broome CV,: Legionnaires’ disease in Vermont, May to October 1978, JAMA 240:127131, 1978.Google Scholar
  17. 17.
    Bock BV, Kirby BD, Edelstein PH, et al: Legionnaires’ disease in renal transplant recipients, Lancet 1: 410–413, 1978.PubMedCrossRefGoogle Scholar
  18. 18.
    Gump DW, Frank RO, Winn WC Jr, et al: Legionnaires’ disease in patients with associated serious disease. Ann Intern Med 90: 538–542, 1979.PubMedGoogle Scholar
  19. 19.
    Haley CE, Cohen ML, Halter J, et al: Nosocomial Legionnaires’ disease: A continuing common-source epidemic at Wadsworth Medical Center. Ann Intern Med 90: 583–586, 1979.PubMedGoogle Scholar
  20. 20.
    England AC III, Fraser DW, Plikaytis BD, et al: Sporadic legionellosis in the United States: The first thousand cases. Ann Intern Med 94: 164–170, 1981.PubMedGoogle Scholar
  21. 21.
    Arnow PM, Chou T, Weil D, et al: Nosocomial Legionnaires’ disease caused by aerosolized tap water from respiratory devices. J Infect Dis 146: 460–467, 1982.PubMedCrossRefGoogle Scholar
  22. 22.
    Pasculle AW, Myerowitz RL, Rinaldo CR: New bacterial agent of pneumonia isolated from renal transplant recipients. Lancet 2: 58–61, 1979.PubMedCrossRefGoogle Scholar
  23. 23.
    Myerowitz RL, Pasculle AW, Dowling JN, et al: Opportunistic lung infection due to “Pittsburgh pneumonia agent.” N Engl J Med 301: 953–958, 1979.PubMedCrossRefGoogle Scholar
  24. 24.
    Rogers BH, Donowitz GR, Walker GK, et al: Opportunistic pneumonia: A clinicopathogenic study of five cases caused by an unidentified acid-fast bacterium. N Engl J Med 301: 495–961, 1979.CrossRefGoogle Scholar
  25. 25.
    Muder RR, Yu VL, Zuravleff JJ: Pneumonia due to the Pittsburgh Pneumonia Agent: New clinical perspective with a review of the literature. Medicine (Baltimore) 62: 120128, 1983.Google Scholar
  26. 26.
    Rudin JE, Wing EJ: A comparative study of Legionella micdadei and other nosocomial acquired pneumonias. Chest 86: 675–680, 1984.PubMedCrossRefGoogle Scholar
  27. 27.
    Aisner J, Schimpff SC, Benett JE, et al: Aspergillus infections in cancer patients: Association with fireproofing materials in a new hospital. JAMA 235: 411–413, 1976.PubMedCrossRefGoogle Scholar
  28. 28.
    Arnow PM, Andersen P, Mainous PD, et al: Pulmonary aspergillosis during hospital renovation. Am Rev Respir Dis 118: 49–53, 1978.PubMedGoogle Scholar
  29. 29.
    Burton JR, Sachery JB, Bessin R, et al: Aspergillosis in four renal transplant patients; diagnosis and effective treatment with Amphoterocin B. Ann Intern Med 77: 383–388, 1972.PubMedGoogle Scholar
  30. 30.
    Rose HD: Mechanical control of hospital ventilation and aspergillus infections. Am Rev Respir Dis 105: 306–307, 1972.PubMedGoogle Scholar
  31. 31.
    Sarubbi FA Jr, Kopf HB, Wilson MB, et al: Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis 125: 33–38, 1982.PubMedGoogle Scholar
  32. 32.
    Rhame FS, Streifel AJ, Kersey JH Jr, et al: Extrinsic risk factors for pneumonia in the patient at high risk of infection. Am J Med 75 (5A): 42–52, 1984.CrossRefGoogle Scholar
  33. 33.
    Opal SM, Asp AA, Cannady PB Jr, et al: Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 153: 634–637, 1986.PubMedCrossRefGoogle Scholar
  34. 34.
    Hopkins CC, Weber D, Rubin RH: Non-domiciliary, nosocomial epidemic of invasive aspergillosis: A common source epidemic due to construction in a radiology suite. Amer Rev Resp Dis (in press), 1986.Google Scholar
  35. 35.
    Singer C, Armstrong D, Rosen PP,: Pneumocystis carinii pneumonia: A cluster of 11 cases. Am J Med 82: 77 2777, 1975.Google Scholar
  36. 36.
    Sickles EA, Greene WH, Wiernik PH: Unusual presentation of infection in granulocytopenic patients. Arch Intern Med 135: 715–719, 1975.PubMedCrossRefGoogle Scholar
  37. 37.
    Zornoza J, Goldman AM, Wallace S, et al: Radiologie fea tures of gram-negative pneumonias in the neutropenic patient. 127: 989–996, 1976.Google Scholar
  38. 38.
    Bodey GP, Buckley M, Sathe YS, et al: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. AJR 64: 328–340, 1966.Google Scholar
  39. 39.
    Rubin RH: Systemic mycotic infections. In Rubenstein E, Federman DD (eds): Scientific. American’s Medicine. Section 7, Subsection IX. Scientific American, New York, 1987, pp. I - 20.Google Scholar
  40. 40.
    Millar JW, Home NW: Tuberculosis in immunosuppressed patients. Lancet 1: 1 176–1180, 1979.Google Scholar
  41. 41.
    Kaplan MH, Armstrong D, Rosen P: Tuberculosis complicating neoplastic disease. Cancer 33: 850–858, 1974.PubMedCrossRefGoogle Scholar
  42. 42.
    Feld R, Bodey GP, Groschel D: Mycobacteriosis in patients with malignant disease. Arch Intern Med 136: 67–78, 1976.PubMedCrossRefGoogle Scholar
  43. 43.
    Roberts CJ: Coccidioidomycosis in acquired immune deficiency syndrome: Depressed humoral as well as cellular immunity. Am J Med 76: 734–736, 1984.PubMedCrossRefGoogle Scholar
  44. 44.
    Bonner JR, Alexander WJ, Dismukes WE, et al: Disseminated histoplasmosis in patients with the acquired immune deficiency syndrome. Arch Intern Med 144: 2178–2181, 1984.PubMedCrossRefGoogle Scholar
  45. 45.
    Taylor MN, Baddour LM, Alexander JR: Disseminated histoplasmosis associated with the acquired immune deficiency syndrome. Am J Med 77: 579–580, 1984.PubMedCrossRefGoogle Scholar
  46. 46.
    Wheat LJ, Slama TG, Zeckel ML: Histoplasmosis in the acquired immune deficiency syndrome. Am J Med 78: 203210, 1985.Google Scholar
  47. 47.
    Scowden EB, Schaffner W, Stone WJ: Overwhelming strongyloidiasis: An unappreciated opportunistic infection. Medicine (Baltimore) 57: 527–544, 1978.Google Scholar
  48. 48.
    Morgan JS, Schaffner W, Stone WJ: Opportunistic strongyloidiasis in renal transplant recipients. Transplantation (in press), 1986.Google Scholar
  49. 49.
    Meyer RD, Young LS, Armstrong D, et al: Aspergillosis complicating neoplastic disease. Am J Med 54: 6–15, 1973.PubMedCrossRefGoogle Scholar
  50. 50.
    Rubin RH, Cosimi AB, Tolkoff-Rubin NE, et al: Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients, Transplantation 24: 458–464, 1977.PubMedCrossRefGoogle Scholar
  51. 51.
    Rubin RH, Cosimi AB: Infection in the immunocompromised host. 2nd ed. In Simmons RL, Howard R (eds): Surgical Infectious Disease,Appleton-Century Crofts, E. Norwalk, Connecticut, 1987, (in press).Google Scholar
  52. 52.
    Masur H, Cheigh JS, Stubanbord WT: Infection following kidney transplantation: A changing pattern. Rev Infect Dis 6: 1208–1219, 1982.CrossRefGoogle Scholar
  53. 53.
    Rubin RH, Wolfson JS, Cosimi AB, et al: Infection in the renal transplant patient. Am J Med 70: 405–411, 1981.PubMedCrossRefGoogle Scholar
  54. 54.
    Weitzman SA, Aisenberg AC: Fulminant sepsis after the successful treatment of Hodgkin’s disease. Am J Med 62: 47–50, 1977.PubMedCrossRefGoogle Scholar
  55. 55.
    Weitzman SA, Aisenberg AC, Siber GR, et al: Impaired humoral immunity in treated Hodgkin’s disease. N Engl J Med 297: 245–248, 1977.PubMedCrossRefGoogle Scholar
  56. 56.
    Siber GR, Weitzman SA, Aisenberg AC, et al: Impaired antibody response to pneumococcal vaccines after treatment for Hodgkin’s disease. N Engl J Med 299: 442–446, 1978.PubMedCrossRefGoogle Scholar
  57. 57.
    Burke BA, Good RA: Pneumoc_ysti.s carinii infection. Medi- 79. Tryka AF, Skornik WA, Godleski JJ,: Potentiation of Bine (Baltimore) 52: 23–49, 1973.Google Scholar
  58. 58.
    Rand KH, Pollard RB, Merigan TC: Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection. N Engl J Med 298: 951–953, 1978.PubMedCrossRefGoogle Scholar
  59. 59.
    Masur H, Shelhamer J, Parrillo JE: The management of pneumonias in immunocompromised patients. JAMA 253: 1769–1773, 1985.PubMedCrossRefGoogle Scholar
  60. 60.
    Gross NJ: Pulmonary effects of radiation therapy. Ann Intern Med 86: 81–92, 1977.PubMedGoogle Scholar
  61. 61.
    Jennings FL, Arden A: Development of radiation pneumonitis. Time and dose factors. Arch Pathol Lab Med 74: 351–360, 1962.Google Scholar
  62. 62.
    Teates, CD: The effects of unilateral thoracic irradiation on pulmonary blood flow. AJR 102: 875–882, 1968.Google Scholar
  63. 63.
    Margolis LW, Phillips TL: Whole-lung irradiation for meta-static tumor. Radiology 93: 1173–1179, 1969.PubMedGoogle Scholar
  64. 64.
    Deeley TJ: The effects of radiation on the lungs in the treat-ment of carcinoma of the bronchus. Clin Radial 11:33–39Google Scholar
  65. 65.
    Fleming JAC, Filbee JF, Wiernik G: Sequelae to radical irradiation in carcinoma of the breast. An inquiry into the incidence of certain radiation injuries. Br J Radio 34: 713–719, 1961.Google Scholar
  66. 66.
    Lougheed MN, Maguire GH: Irradiation pneumonitis in the treatment of carcinoma of the breast. J Can Assoc Radiol 11: 1–9, 1960.Google Scholar
  67. 67.
    Whitfield AGW, Bond WH, Kunkler PB: Radiation damage to thoracic tissues. Thorax 18: 371–380, 1963.PubMedCrossRefGoogle Scholar
  68. 68.
    Boushy SF, Helgason AH, North LB: The effect of radiation on the lung and bronchial tree. AJR 108: 284–292, 1970.Google Scholar
  69. 69.
    Phillips TL, Wharam MD, Margolis LW: Modification of radiation injury to normal tissues by chemotherapeutic agents. Cancer 35: 1678–1684, 1975.PubMedCrossRefGoogle Scholar
  70. 70.
    Castellino RA, Glatstein E, Turbow MM, et al: Latent radia-tion injury of lung or heart activated by steroid withdrawal. Ann Intern Med 80: 593–599, 1974.PubMedGoogle Scholar
  71. 71.
    Kun LE, DeVita VT, Young RC, et al: Treatment of Hodgkin’s disease using intensive chemotherapy followed by irradiation. Int J Radiat Oncol Biol Phys 1: 619–626, 1976.PubMedCrossRefGoogle Scholar
  72. 72.
    Poussin-Rosillo H, Nisce LZ, et al: Complications of total nodal irradiation of Hodgkin’s disease stages III and IV. Cancer 42: 437–441, 1978PubMedCrossRefGoogle Scholar
  73. 73.
    Goldman AL, Enquist R: Hyperacute radiation pneumonitis. Chest 67: 613–615, 1975.PubMedCrossRefGoogle Scholar
  74. 74.
    Roswit B, White DC: Severe radiation injuries of the lung. AJR 129: 127–136, 1977.PubMedGoogle Scholar
  75. 75.
    Rosenow EC III: The spectrum of drug-induced pulmonary disease. Ann Intern Med 77: 977–991, 1972.PubMedGoogle Scholar
  76. 76.
    Brettner A, Heitzman ER, Woodin WG: Pulmonary complications of drug therapy. Radiology 96: 31–38, 1970.PubMedGoogle Scholar
  77. 77.
    Whitcomb ME: Drug-induced lung disease. Chest 63: 418–422, 1973. 1973.Google Scholar
  78. 78.
    Goldiner PL, Schweizer O: The hazards of anesthesia and surgery in bleomycin-treated patients. Semin Oncol 6: 121–124, 1979.PubMedGoogle Scholar
  79. 79.
    Tryka AF, Skornik WA, Godleski JJ, et al: Potentiation of bleomycin-induced lung injury by exposure to 70% oxygen:Morphologic assessment. Am Rev Respir Dis 126: 1074–1079, 1982.PubMedGoogle Scholar
  80. 80.
    Einhorn L, Krause M, Hornback N, et al: Enhanced pulmo nary toxicity with bleomycin and radiotherapy in oat cell lung cancer. Cancer 37: 2414–2416, 1976.PubMedCrossRefGoogle Scholar
  81. 81.
    Littler WA, Ogilvie C: Lung function in patients receiving busulphan. Br Med J 4: 530–532, 1970.PubMedCrossRefGoogle Scholar
  82. 82.
    Rodman T, Karr S, Close HP: Radiation reaction in the lung. Report of a fatal case in a patient with carcinoma of the lung, with studies of pulmonary function before and during pred nisone therapy. N Engl J Med 262: 431–434, 1960.PubMedCrossRefGoogle Scholar
  83. 83.
    Brady LW, Germon PA, Cander L: The effects of radiation therapy on pulmonary function in carcinoma of the lung. Radiology 85: 130–134, 1965.PubMedGoogle Scholar
  84. 84.
    Sostman HD, Matthay RA, Putman CE: Cytotoxic drug induced lung disease. Am J Med 62: 608–615, 1977.PubMedCrossRefGoogle Scholar
  85. 85.
    Willson JVK: Pulmonary toxicity of antineoplastic drugs. Cancer Treatm Rep 62: 2003–2008, 1978.Google Scholar
  86. 86.
    Holoye PY, Luna MA, MacKay B, et al: Bleomycin hyper sensitivity pneumonitis. Ann Intern Med 88: 47–49, 1978.PubMedGoogle Scholar
  87. 87.
    Rosenow EC III: Chemotherapeutic drug-induced pulmo nary disease. Semin Respir Med 2: 89–96, 1980.CrossRefGoogle Scholar
  88. 88.
    Collis CH: Lung damage from cytotoxic drugs. Cancer Chemother Pharmacol 4: 17–27, 1980.PubMedCrossRefGoogle Scholar
  89. 89.
    Weiss RB, Muggia FM: Cytotoxic drug-induced pulmonary disease. Am J Med 68: 259–266, 1980.PubMedCrossRefGoogle Scholar
  90. 90.
    Batist G, Andrews JL Jr: Pulmonary toxicity of anti neoplastic drugs. JAMA 246: 1449–1453, 1981.PubMedCrossRefGoogle Scholar
  91. 91.
    Ginsberg SJ, Comis RL: The pulmonary toxicity of anti neoplastic agents. Semin Oncol 9: 34–51, 1982.PubMedGoogle Scholar
  92. 92.
    Oliner H, Schwartz R, Rubio F Jr, et al: Interstitial pulmo nary fibrosis following busulfan therapy. Am J Med 31: 134–139, 1961.PubMedCrossRefGoogle Scholar
  93. 93.
    Leake E, Smith WG, Woodliff HJ: Diffuse interstitial pul monary fibrosis after busulphan therapy. Lancet 2: 432–434, 1963.PubMedCrossRefGoogle Scholar
  94. 94.
    Heard BE, Cooke RA: Busulphan lung. Thorax 23: 187–193, 1968.PubMedCrossRefGoogle Scholar
  95. 95.
    Kirschner RH, Esterly JR: Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia. Cancer 27: 1074–1080, 1971.PubMedCrossRefGoogle Scholar
  96. 96.
    Manning DM, Strimlan CV, Turbiner EH: Early detection of busulfan lung: Report of a case. Clin Nucl Med 5: 412–414, 1980.PubMedCrossRefGoogle Scholar
  97. 97.
    Hankins DG, Sanders S, MacDonald FM, et al: Pulmonary toxicity recurring after a six week course of busulfan therapy and after subsequent therapy with uracil mustard. Chest 73: 415–416, 1978.PubMedCrossRefGoogle Scholar
  98. 98.
    Horowitz AL, Friedman M, Smith J, et al: The pulmonary changes of bleomycin toxicity, Radiology 106: 65–68, 1973.PubMedGoogle Scholar
  99. 99.
    Blum RH, Carter SK, Agre K: A clinical review of bleomy cin-A new antineoplastic agent, Cancer 31: 903–914, 1973.PubMedCrossRefGoogle Scholar
  100. 100.
    Pascual RS, Mosher MB, Sikand RS, et al: Effects of bleo mycin on pulmonary function in man, Am Rev Respir Dis 108: 211–217, 1973.PubMedGoogle Scholar
  101. 101.
    Samuels ML, Johnson DE, Itoloye PY, et al: Large-dose bleomycin therapy and pulmonary toxicity: A possible role of prior radiotherapy. JAMA 235:1117–1120, 1976.Google Scholar
  102. 102.
    lacovino JR, Leitner J, Abbas AK, et al: Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue response. JAMA 235:1253–1255, 1976.Google Scholar
  103. 103.
    Perez-Guerra F, Harkleroad LE, Walsh RE, et al: Acute bleomycin lung. AM Rev Respir Dis 106: 909–913, 1972.PubMedGoogle Scholar
  104. 104.
    Brown WG, Hasan FM, Barbee RA: Reversibility of severe bleomycin-induced pneumonitis. JAMA 239:2012–2014, 1978.Google Scholar
  105. 105.
    Aronin PA, Mahaley MS Jr, Rudnick SA, et al: Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: An assessment of risk factors. N Engl J Med 303:183188, 1980.Google Scholar
  106. 106.
    Durant JR, Norgard MI, Murad TM, et al: Pulmonary toxicity associated with bischloroethyl nitrosourea (BCNU). Ann Intern Med 90:191–194, 1979.Google Scholar
  107. 107.
    Rodin AE, Haggard ME, Travis LB: Lung changes and chemotherapeutic agents in childhood: Report of a case associated with cyclophosphamide therapy. Am J Dis Child 120:337–340, 1970.Google Scholar
  108. 108.
    Dohner VA, Ward HP, Standard RE: Alveolitis during procarbazine, vincristine and cyclophosphamide therapy. Chest 62: 636–639, 1972.PubMedCrossRefGoogle Scholar
  109. 109.
    Patel AR, Shah PC, Rhee HL, Sassoon H, Rao KP: Cycoophosphamide therapy and interstitial pulmonary fibrosis. Cancer 38:1542–1549, 1976.Google Scholar
  110. 110.
    Rubio FA: Possible pulmonary effects of alkylating agents. N Engl J Med 287:1150–1151, 1972.Google Scholar
  111. 111.
    Rose MS: Busulphan toxicity syndrome caused by chlorambucil. Br Med J 2:123–127, 1975.Google Scholar
  112. 112.
    Godard P, Marty JP, Michel FB: Interstitial pneumonia and chlorambucil. Chest 76: 471–473, 1979.PubMedCrossRefGoogle Scholar
  113. 113.
    Clarysse AM, Cathey WJ, Cartwright GE, et al: Pulmonary disease complicating intermittent therapy with methotrexate. JAMA 209:1861–1864, 1969.Google Scholar
  114. 114.
    Whitcomb ME, Schwarz MI, Tormey DC: Methotrexate pneumonitis: Case report and review of the literature. Thorax 27: 636–639, 1972.PubMedCrossRefGoogle Scholar
  115. 115.
    Goldman GC, Moschella SL: Severe pneumonitis occurring during methotrexate therapy. Report of two cases. Arch Dermatol 103:194–197, 1971.Google Scholar
  116. 116.
    Everts CS, Westcott JL, Bragg DG: Methotrexate therapy and pulmonary disease. Radiology 107: 539–543, 1973.PubMedGoogle Scholar
  117. 117.
    Lisbona A, Schwartz J, Lachance C,: Methotrexateinduced pulmonary disease. J Can Assoc Radiol 24: 215220, 1973.Google Scholar
  118. 118.
    Sostman HD, Matthay RA, Putman CE, et al: Methotrexateinduced pneumonitis. Medicine (Baltimore) 55: 371–388, 1976.CrossRefGoogle Scholar
  119. 119.
    Gutin PH, Green MR, Bleyer WA, et al: Methotrexate pneumonitis induced by intrathecal methotrexate therapy: A case report with pharmacokinetic data. Cancer 38 :1529–1534, 1976.Google Scholar
  120. 120.
    Lascari AD, Strano Ai, Johnson WW,: Methotrexateinduced sudden fatal pulmonary reaction. Cancer 40:13931397, 1977.Google Scholar
  121. 121.
    Rosenow EC III, Unni KK: Drug-induced pulmonary granulomas. Lung Biol Health Dis 20: 469–484, 1983.Google Scholar
  122. 122.
    Cooperative study: Acute lymphocytic leukemia in children. Maintenance therapy with methotrexate administered intermittently. Acute leukemia group B. JAMA 207: 923928, 1969.Google Scholar
  123. 123.
    Codling BW, Chakera TM: Pulmonary fibrosis following therapy with melphalan for multiple myeloma. J Clin Pathol 25: 668–673, 1972.PubMedCrossRefGoogle Scholar
  124. 124.
    Rubin G, Baume P, Vandenberg R: Azathioprine and acute restrictive lung disease. Aust NZ J Med 2: 272–274, 1972.CrossRefGoogle Scholar
  125. 125.
    Hazlett DR, Ward GW, Madison DS: Pulmonary function loss in diphenylhydantoin therapy. Chest 66: 660–664, 1974.PubMedCrossRefGoogle Scholar
  126. 126.
    Marshall A, Moore K: Pulmonary disease after amitriptyline overdosage. Br Med J 1:716–717, 1973.Google Scholar
  127. 127.
    Winterbauer RH, Wilske KR, Wheelis RF: Diffuse pulmonary injury associated with gold treatment. N Engl J Med 294: 919–921, 1976.PubMedCrossRefGoogle Scholar
  128. 128.
    Whitcomb ME, Schwarz MI, Keller AR, et al: Hodgkin’s disease of the lung. Am Rev Respir Dis 106: 79–85, 1972.PubMedGoogle Scholar
  129. 129.
    Martin JJ The Nisbet Symposium: Hodgkin’s disease. Radiological aspects of the disease. Australas Radiol 11:206218, 1967.Google Scholar
  130. 130.
    Strickland B: Intra-thoracic Hodgkin’s disease. Part II. Peripheral manifestations of Hodgkin’s disease in the chest. Br J Radiol 40:930–938, 1967.Google Scholar
  131. 131.
    Fraser RG, Paré JAP (eds): Neoplastic diseases of the lungs. In Diagnosis of Diseases of the Chest. Vol. II. 2nd ed. WB Saunders, Philadelphia, 1978, pp. 981–1134.Google Scholar
  132. 132.
    Rosenberg SA, Diamond HD, Jaslowitz B, et al: Lymphosarcoma: A review of 1269 cases. Medicine (Baltimore) 40: 31–84, 1961.CrossRefGoogle Scholar
  133. 133.
    Rose HA: Primary lymphosarcoma of the lung. J Thorac Cardiovasc Surg 33: 254–263, 1957.Google Scholar
  134. 134.
    Baron MG, Whitehouse WM: Primary lymphosarcoma of the lung. AJR 85: 294–308, 1961.Google Scholar
  135. 135.
    Vernant JP, Brun B, Mannoni P,: Respiratory distress of hyperleukocytic granulocytic leukemias. Cancer 44: 264268, 1979.Google Scholar
  136. 136.
    McKee LC Jr, Collins RD: Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Medicine (Baltimore) 53: 463–478, 1974.CrossRefGoogle Scholar
  137. 137.
    Myers TJ, Cole SR, Klatsky AU, et al: Respiratory failure due to pulmonary leukostasis following chemotherapy of acute non-lymphocytic leukemia. Cancer 51:1808–1813, 1983.Google Scholar
  138. 138.
    Tryka AF, Godleski ii, Fanta CH: Leukemic cell lysis pneumonopathy: A complication of treated myeloblastic leukemia. Cancer 50: 2763–2770, 1982.PubMedCrossRefGoogle Scholar
  139. 139.
    Green RA, Nichlos NJ: Pulmonary involvement in leukemia. Am Rev Respir Dis 80: 833–844, 1959.Google Scholar
  140. 140.
    Blank N, Castellino RA, Shah V: Radiographic aspects of pulmonary infection in patients with altered immunity. Radiol Clin North Am 11 :175–190, 1973.Google Scholar
  141. 141.
    Simmons RL, Uranga VM, LaPlante ES,: Pulmonary complications in transplant recipients. Arch Surg 105: 260268, 1972.Google Scholar
  142. 142.
    Friedman M, Libert R, Michaelson ED: Unilateral pulmonary edema after renal transplantation. N Engl J Med 293: 343–344, 1975.PubMedCrossRefGoogle Scholar
  143. 143.
    Ward HN: Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 73: 689–694, 1970.PubMedGoogle Scholar
  144. 144.
    Thompson JS, Severson CD, Parmely MJ, et al: Pulmonary “hypersensitivity” reactions induced by transfusion of non-HL-A leukoagglutinins. N Engl J Med 284:1120–1125, 1971.Google Scholar
  145. 145.
    Tenholder MF, Hooper RG: Pulmonary infiltrates in leukemia. Chest 78: 468–473, 1980.PubMedCrossRefGoogle Scholar
  146. 146.
    Popovsky MA, Abel MD, Moore SB: Transfusion-related acute lung injury associated with passive transfer of anti-leukocyte antibodies. Am Rev Respir Dis 128: 185–189, 1983.PubMedGoogle Scholar
  147. 147.
    Roswit B, White DC: Severe radiation injuries of the lung. AJR 129: 127–136, 1977.PubMedGoogle Scholar
  148. 148.
    Aisner J, Schimpff SC, Wiernik PH: Treatment of invasive aspergillosis: Relation of early diagnosis and treatment to response. Ann Intern Med 86:539–543, 1977.Google Scholar
  149. 149.
    Schaefer JC, Yu B, Armstrong D: An aspergillus immunodiffusion test in the early diagnosis of aspergillosis in adult leukemia patients. Am Rev Respir Dis 113: 325–329, 1976.PubMedGoogle Scholar
  150. 150.
    Filice G, Yu B, Armstrong D: Immunodiffusion and agglutination tests for candida in patients with neoplastic disease: Inconsistent correlation of results with invasive disease. J Infect Dis 135: 349–357, 1977.PubMedCrossRefGoogle Scholar
  151. 151.
    Edwards JE Jr, Lehrer RI, Stiehm ER, et al: Severe candidal infections: Clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med 89:91–106, 1978.Google Scholar
  152. 152.
    Fisher BD, Armstrong D: Cryptococcal interstitial pneumonia: Value of antigen determination. N Engl J Med 297:1440–1441, 1977.Google Scholar
  153. Jensen WA, Rose RM, Hammer SM,: Serologic diagnosis of focal pneumonia caused by Cryptococcus neoformans. Am Rev Respir Dis 132:198–200 1985.Google Scholar
  154. Shaffer PI, Medoff G, Kobayashi GS: Demonstration of antigenemia by radioimmunoassay in rabbits experimentally infected with Aspergillus. J Infect Dis 139:313–319 1979.Google Scholar
  155. 155.
    Weiner MH, Talbot GH, Gerson SL, et al: Antigen detection in the diagnosis of invasive aspergillosis; utility in controlled blinded trials. Ann Intern Med 99: 777–784, 1983.PubMedGoogle Scholar
  156. 156.
    Kiehn TE, Bernard EM, Gold JWM, et al: Candidiasis: Detection by gas-liquid chromatography of o-arabinitol, a fungal metabolite, in human serum. Science 206: 577–580, 1979.PubMedCrossRefGoogle Scholar
  157. 157.
    Murray PR, Washington JA II: Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 50: 339–344, 1975.PubMedGoogle Scholar
  158. 158.
    Bodey GP, Powell RD, Hersh EM, et al: Pulmonary complications of acute leukemia. Cancer 19: 781–793, 1966.PubMedCrossRefGoogle Scholar
  159. 159.
    Sickles EA, Young VM, Greene WH, et al: Pneumonia in acute leukemia. Ann Intern Med 79: 528–534, 1973.PubMedGoogle Scholar
  160. 160.
    Aisner J, Kuols LK, Sickles EA, et al: Transtracheal selective bronchial brushing for pulmonary infiltrates in patients with cancer. Chest 69: 367–371, 1976.PubMedCrossRefGoogle Scholar
  161. 161.
    Walzer PD, Pen DP, Krogstad DJ,: Pneumocystis carinii pneumonia in the United States: Epidemiologic, diagnostic, and clinical features. Ann Intern Med 80: 83–93, 1974.PubMedGoogle Scholar
  162. 162.
    Lau WK, Young LS, Remington JS: Pneumocystis carinii pneumonia: Diagnosis by examination of pulmonary secretions. JAMA 236: 2399–2402, 1976.PubMedCrossRefGoogle Scholar
  163. 163.
    Barlett JG: Diagnostic accuracy of transtracheal aspiration: Bacteriologic studies. Am Rev Respir Dis 115: 777–782, 1977.Google Scholar
  164. 164.
    Hahn HH, Beaty HN: Transtracheal aspiration in the evaluation of patients with pneumonia. Ann Intern Med 72:183187,1970.Google Scholar
  165. 165.
    Ries K, Levison ME, Kaye D: Transtracheal aspiration in pulmonary infection. Arch Intern Med 133: 453–458, 1973.CrossRefGoogle Scholar
  166. 166.
    Davidson M, Tempest B, Palmer DL: Bacteriologic diagnosis of acute pneumonia: Comparison of sputum, trans-tracheal aspirates, and lung aspirates. JAMA 235:158–163, 1976.Google Scholar
  167. 167.
    Matthay RA, Moritz ED: Invasive procedures for diagnosing pulmonary infection: A critical review. Clin Chest Med 2: 319, 1981.Google Scholar
  168. 168.
    Bartlett JG, Alexander J, Mayhew J, et al: Should fiberoptic bronchoscopy aspirates be cultured? Am Rev Respir Dis 114: 73–78, 1976.PubMedGoogle Scholar
  169. 169.
    Thiede WH, Banaszak GF: Selective bronchial catheterization. N Engl J Med 286: 525–528, 1972.CrossRefGoogle Scholar
  170. Repsher LH, Schroter G, Hammon WS: Diagnosis of Pneumocystis carinii. N Engl J Med 287:340–341 1972.Google Scholar
  171. 171.
    Finley R, Kieff E, Thompson S, et al: Bronchial brushing in the diagnosis of pulmonary disease in patients at risk for opportunistic infection. Am Rev Respir Dis 109: 379–386, 1974.PubMedGoogle Scholar
  172. 172.
    Zavala DC, Bedell GN, Rossi NP: Trephine Lung biopsy with a high-speed air drill. J Thorac Cgrdiovasc Surg 64: 220–228, 1972.Google Scholar
  173. 173.
    McCartney RL: Hemorrhage following percutaneous lung biopsy. Radiology 112: 305–307, 1974.PubMedGoogle Scholar
  174. 174.
    Bandt PD, Blank N, Castellino RA: Needle diagnosis of pneumonitis. Value in high-risk patients, JAMA 220:15781583,1972.Google Scholar
  175. 175.
    Greenman RL, Goodall PT, King D: Lung biopsy in immunocompromised hosts. Am J Med 59: 488–497, 1975.PubMedCrossRefGoogle Scholar
  176. 176.
    Krick JA, Stinson EB, Remington JS: Nocardia infection in heart transplant patients. Ann Intern Med 82:18–26, 1975.Google Scholar
  177. 177.
    Zavala DC, Schoell JE: Ultrathin needle aspiration of the lung in infectious and malignant disease. Am Rev Respir Dis 123: 125–131, 1981.PubMedGoogle Scholar
  178. 178.
    Bandt PD, Blank N, Castellino RA: Needle diagnosis of pneumonitis; value in high-risk patients. JAMA 220:15781580,1972.Google Scholar
  179. 179.
    Wimberley N, Faling LI, Bartlett JG: A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture. Am Rev Respir Dis 119:337343, 1979.Google Scholar
  180. 180.
    Winterbauer RH, Hutchinson JF, Reinhardt GN, et al: The use of quantitative cultures and antibody coating of bacteria to diagnose bacterial pneumonia by fiberoptic bronchoscopy. Am Rev Respir Dis 128:98–103, 1983.Google Scholar
  181. 181.
    Ellis JH Jr.: Transbronchial lung biopsy via the fiberoptic bronchoscope: Experience with 107 consecutive cases and comparison with bronchial brushing. Chest 68: 524–532, 1975.PubMedCrossRefGoogle Scholar
  182. 182.
    Cunningham JH, Zarala DC, Cony RJ, et al: Trephine air drill, bronchial brush, and fiberoptic transbronchial lung biopsies in immunosuppressed patients. Am Rev Respir Dis 115: 213–220, 1977.PubMedGoogle Scholar
  183. 183.
    Ellis JH Jr: Diagnosis of opportunistic infections using the flexible fiberoptic bronchoscope. Chest (Suppl) 73: 713715, 1978.Google Scholar
  184. 184.
    Matthay RA, Farmer WC, Odero D: Diagnostic fiberoptic bronchoscopy in the immunocrompromised host with pulmonary infiltrates. Thorax 32: 539–545, 1977.PubMedCrossRefGoogle Scholar
  185. 185.
    George RB, Jenkinson SG, Light RW: Fiberoptic bronchoscopy in the diagnosis of pulmonary fungal and nocardial infections. Chest 73: 33–36, 1978.PubMedCrossRefGoogle Scholar
  186. 186.
    Stover DE, Zaman MB, Hajdu SI, et al: Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med 101:1–7, 1984.Google Scholar
  187. 187.
    Coleman DL, Dodek PM, Luce JM, et al: Diagnostic utility of fiberoptic bronchoscopy in patients with Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Respir Dis 128: 795–799, 1983.PubMedGoogle Scholar
  188. 188.
    Murray JF, Felton CP, Garay SM, et al: Pulmonary complications of the acquired immunodeficiency syndrome. N Engl J Med 310:1682–1688, 1984.Google Scholar
  189. 189.
    Young JA, Hopkin JM, Cuthbertson WP: Pulmonary infiltrates in immunocompromised patients: Diagnosis by cytological examination of bronchoalveolar lavage fluid. J Clin Pathol 37: 390–397, 1984.PubMedCrossRefGoogle Scholar
  190. 190.
    Beyt BE Jr, King DK, Glew RH: Fatal pneumonitis and septicemia after fiberoptic bronchoscopy. Chest 72: 105107, 1977.Google Scholar
  191. 191.
    Robbins H, Goldman AL: Failure of a “prophylactic” antimicrobial drug to prevent sepsis after fiberoptic bronchoscopy. Am Rev Respir Dis 116: 325–326, 1977.PubMedGoogle Scholar
  192. 192.
    Dijkman JH, van der Meer JWM, Bakker W, et al: Trans-pleural lung biopsy by the thoracoscopic route in patients with diffuse interstitial pulmonary disease. Chest 82:76–83, 1982.Google Scholar
  193. 193.
    Lloyd MS: Thoracoscopy and biopsy in the diagnosis of pleurisy with effusion. Q Bull Sea View Hosp 14:128–133, 1953.Google Scholar
  194. 194.
    DeCamp PT, Mosley PW, Scott ML, et al: Diagnostic thoracoscopy. Ann Thorac Surg 16: 79–84, 1973.CrossRefGoogle Scholar
  195. 195.
    Oldenburg FA, Newhouse MT: Thoracoscopy: A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia. Chest 75: 45–50, 1979.PubMedCrossRefGoogle Scholar
  196. 196.
    Toledo-Pereyra LH, DeMeester TR, Kinealey A, et al: The benefit of open lung biopsy in patients with previous non-diagnostic transbronchial lung biopsy; a guide to appropriate therapy. Chest 77: 647–650, 1980.PubMedCrossRefGoogle Scholar
  197. 197.
    Jaffe JP, Maki DG: Lung biopsy in immunocompromised patients: One institution’s experience and an approach to management of pulmonary disease in the compromised host. Cancer 48:1144–1153, 1981.Google Scholar
  198. 198.
    Haverkos HW, Dowling JN, Pasculle AW, et al: Diagnosis of pneumonitis in immunocompromised patients by open lung biopsy. Cancer 52:1093–1097, 1983.Google Scholar
  199. 199.
    McKenna RJ Jr, Mountain CF, McMurtrey Mk Open lung biopsy in immunocompromised patients. Chest 86: 67 1674, 1984.Google Scholar
  200. 200.
    Cockerill FR III Wilson WR, Carpenter HA,: Open lung biopsy in immunocompromised patients. Arch Intern Med 145:1398–1404 1985.Google Scholar
  201. 201.
    Cheson BD, Samlowski WE, Tang TT, et al: Value of open-lung biopsy in 87 immunocompromised patients with pulmonary infiltrates. Cancer 55: 453–459, 1985.PubMedCrossRefGoogle Scholar
  202. 202.
    Maile CW, Moore AV, Ulreich S, et al: Chest radiographic-pathologic correlation in adult leukemia patients. Invest Radio 18: 495–499, 1983.CrossRefGoogle Scholar
  203. 203.
    McCabe RE, Brooks RG, Mark JBD, et al: Open lung biopsy in patients with leukemia. Am J Med 78: 609–616, 1985.PubMedCrossRefGoogle Scholar
  204. 204.
    Murray JF, Felton CP, Gonay SM, et al: Pulmonary complications of the acquired immunodeficiency syndrome: Report of a National Heart, Lung, and Blood Institute Workshop. N Engl J Med 310:1682–1688, 1984.Google Scholar
  205. 205.
    Hopewell PC, Luce JM: Pulmonary involvement in the acquired immune deficiency syndrome. Chest 87:104–112, 1985.Google Scholar
  206. 206.
    Stover DE, White DA, Romano PA, et al: Spectrum of pulmonary disease associated with the acquired immunodeficiency syndrome. Am J Med 78: 429–437, 1985.PubMedCrossRefGoogle Scholar
  207. 207.
    Catterall JR, Potasman I, Remington JS: Pneumocystis carinii pneumonia in the patient with AIDS. Chest 88: 758–762, 1985.PubMedCrossRefGoogle Scholar
  208. 208.
    Talaverda W, Mildvan D: Pulmonary infections in the acquired immunodeficiency syndrome. Semin Respir Infect 1: 202–211, 1986.Google Scholar
  209. 209.
    Coleman DL, Hattner RS, Luce JM, et al: Correlation between gallium lung scan and fiberoptic bronchoscopy in patients with suspected Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Respir Dis 130:1166–1169, 1984.Google Scholar
  210. 210.
    Tuazon CU, Delaney MD, Simon GL, et al: Utility of gallium 67 scintigraphy and bronchial washings in the diagnosis and treatment of Pneumocystis carinii pneumonia in patients with the acquired immune deficiency syndrome. Am Rev Respir Dis 132:1087–1092, 1985.Google Scholar
  211. 211.
    Polsky B, Gold JWM, Whimby E, et al: Bacterial pneumonia in patients with acquired immune deficiency syndrome. Ann Intern Med 104: 38–41, 1986.PubMedGoogle Scholar
  212. 212.
    Betts RF, Freeman RB, Douglas RG, et al: Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child 131: 759–763, 1977.PubMedGoogle Scholar
  213. 213.
    Chatterjee SN, Fiala M, Weiner J, et al: Primary cytomegalovirus and opportunistic infections: Incidence in renal transplant recipients. JAMA 240: 2446–2449, 1978.PubMedCrossRefGoogle Scholar
  214. 214.
    Rand KH Pollard RB, Merigan TC: Increased pulmonary superinfections in cardiac transplant patients undergoing primary cytomegalovirus infection. N Engl J Med 298:951953, 1978.Google Scholar
  215. 215.
    Neiman PE, Reeves W, Ray G,: A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogenic bone marrow grafts J Infect Dis 136 :754–767, 1977 Google Scholar
  216. 216.
    Rubin RH, Russell PS, Levin M, et al: Summary of a workshop on cytomegalovirus infections during organ transplantation. J Infect Dis 134: 728–734, 1979.CrossRefGoogle Scholar
  217. 217.
    Hamilton JR, Overall JC, Glasgow LA: Synergistic effect on mortality in mice with murine cytomegalovirus andPseudomonas aeruginosa Staphylococcus aureus or Candida albicans infection Infect Immun 14 :982–989, 1976 Google Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Robert H. Rubin
    • 1
    • 2
  • Reginald Greene
    • 3
    • 4
  1. 1.Infectious Disease and Transplantation UnitsMassachusetts General HospitalBostonUSA
  2. 2.Department of MedicineHarvard Medical SchoolBostonUSA
  3. 3.Chest Division, Radiology ServiceMassachusetts General HospitalBostonUSA
  4. 4.Department of RadiologyHarvard Medical SchoolBostonUSA

Personalised recommendations